These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17327688)

  • 21. P53 mutation and LOH at chromosome 9 in urothelial carcinoma.
    Beothe T; Nagy A; Farkas L; Kovacs G
    Anticancer Res; 2012 Feb; 32(2):523-7. PubMed ID: 22287741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice.
    Ter Steege EJ; Sijnesael T; Enserink L; Klarenbeek S; Haakma WE; Bakker ERM; Derksen PWB
    Neoplasia; 2023 Jan; 35():100844. PubMed ID: 36371908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of highly frequent allelic loss region on distal chromosome 12 in murine radiation-induced lymphomas.
    Park YG; Song CW; Mori N; Sugimoto K; Hong DP; Okumoto M
    Cancer Lett; 2000 Jan; 148(1):95-103. PubMed ID: 10680598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
    Kuperwasser C; Hurlbut GD; Kittrell FS; Dickinson ES; Laucirica R; Medina D; Naber SP; Jerry DJ
    Am J Pathol; 2000 Dec; 157(6):2151-9. PubMed ID: 11106587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential use of loss of heterozygosity in pleural effusions of breast cancer metastases using the microsatellite marker of the 16q22.1 region of the CDH1 gene.
    Granja Nde M; Ricardo SA; Longatto Filho A; Alves VA; Bedrossian CW; Wiley EL; Schmitt FC
    Anal Quant Cytol Histol; 2005 Apr; 27(2):61-6. PubMed ID: 15913197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
    Shetzer Y; Napchan Y; Kaufman T; Molchadsky A; Tal P; Goldfinger N; Rotter V
    Int J Cancer; 2017 Mar; 140(6):1364-1369. PubMed ID: 28008605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent loss of heterozygosity on chromosomes 4, 12 and 19 in radiation-induced lymphomas in mice.
    Okumoto M; Park YG; Song CW; Mori N
    Cancer Lett; 1999 Jan; 135(2):223-8. PubMed ID: 10096432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelic loss analysis of gamma-ray-induced mouse thymic lymphomas: two candidate tumor suppressor gene loci on chromosomes 12 and 16.
    Matsumoto Y; Kosugi S; Shinbo T; Chou D; Ohashi M; Wakabayashi Y; Sakai K; Okumoto M; Mori N; Aizawa S; Niwa O; Kominami R
    Oncogene; 1998 May; 16(21):2747-54. PubMed ID: 9652741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival.
    Arribas R; Ribas M; Risques RA; Masramon L; Tórtola S; Marcuello E; Aiza G; Miró R; Capellà G; Peinado MA
    Clin Cancer Res; 1999 Nov; 5(11):3454-9. PubMed ID: 10589758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.
    Wiseman RW; Cochran C; Dietrich W; Lander ES; Söderkvist P
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3759-63. PubMed ID: 8170984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome band 16q24 is frequently deleted in human gastric cancer.
    Mori Y; Matsunaga M; Abe T; Fukushige S; Miura K; Sunamura M; Shiiba K; Sato M; Nukiwa T; Horii A
    Br J Cancer; 1999 May; 80(3-4):556-62. PubMed ID: 10408866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
    Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
    Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice.
    Zhuang SM; Eklund LK; Cochran C; Rao GN; Wiseman RW; Söderkvist P
    Cancer Res; 1996 Jul; 56(14):3338-43. PubMed ID: 8764131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.
    Dietrich WF; Radany EH; Smith JS; Bishop JM; Hanahan D; Lander ES
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9451-5. PubMed ID: 7937788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.